コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
3 ts, of whom 59 were randomly assigned to tocilizumab and 59 were randomly assigned to azathioprine.
4 2017, and Aug 3, 2018, we enrolled 118 patients, of whom 59 were randomly assigned to tocilizumab and 59 were randomly as
5 = 70 [24.4%]; MPNST: n = 27 [9.4%]; and LMS: n = 28 [9.8%]) were randomly assigned to either A+I or HT.
6 computer-generated list, T. trichiura-infected adolescents were randomly assigned to 7 treatment arms: 8, 16, or 24 mg o
7 Fifty-four childcare centers in New South Wales, Australia were randomly assigned to the intervention (a web-based menu-
8 ergoing elective colon resection for nonmetastasized cancer were randomly assigned to 2 intravenous n-3 PUFA or saline co
10 tatic urothelial carcinoma, from 221 sites in 35 countries, were randomly assigned to receive atezolizumab plus platinum-
11 ocardial infarction and multivessel coronary artery disease were randomly assigned to one of the following revascularizat
12 Between Oct 1, 2016, and April 30, 2019, 20 facilities were randomly assigned to either the intervention group (n=10
13 who were recently hospitalized for worsening heart failure were randomly assigned to receive sotagliflozin or placebo.
14 ), with refractory agitation, despite low-dose haloperidol, were randomly assigned to receive intravenous haloperidol dos
15 Between June 14, 2015 and Jul 11, 2017, 60 men with HIV were randomly assigned to receive either an ART-only (n=30) o
16 ovember 2016 through November 2017, a total of 1453 infants were randomly assigned to receive nirsevimab (969 infants) or
17 ), abdominally obese or dyslipidemic participants in Israel were randomly assigned to healthy dietary guidelines, Mediter
18 or IIIC (without in-transit metastasis) cutaneous melanoma were randomly assigned to receive pembrolizumab at a flat dos
20 igible (TIE) patients with newly diagnosed multiple myeloma were randomly assigned to D-Rd (n = 368) or Rd (n = 369).
29 week lead-in period of cognitive training, 100 participants were randomly assigned to receive either vortioxetine or plac
31 5, 1027 individuals were screened, of whom 769 participants were randomly assigned to doravirine (n=385) or ritonavir-boo
32 he time of percutaneous coronary intervention, participants were randomly assigned to prospective rapid point-of-care gen
34 In the historical control trial, participants were randomly assigned to either one dose or two doses of mon
39 From September 2014 to June 2018, patients were randomly assigned to groups that received the prophylaxi
40 Between July 19, 2016, and Oct 31, 2017, 291 patients were randomly assigned to receive venetoclax (n=194) or place
41 Between July 31, 2013, and June 22, 2015, 437 patients were randomly assigned to either placebo (n=108) or cenobamat
42 Between March 11, 2016, and June 22, 2018, 62 patients were randomly assigned to nivolumab (n = 30) or nivolumab plu
43 nfirmation of TNBC status by immunohistochemistry, patients were randomly assigned to either capecitabine or observation.
45 ed to be deriving benefit despite radiographic progression, were randomly assigned to continue nivolumab until disease pr
46 metastatic CRC previously treated with one or two regimens were randomly assigned to irinotecan and cetuximab with or wi
47 -wk run-in period on a nitrate-restricted diet the subjects were randomly assigned to receive 1 of the following 3 interv
48 After this initial treatment, subjects were randomly assigned to group 1 (1 TMP-SMZ dose every other
49 emala included 26 mother-infant dyads 4-6 mo postpartum who were randomly assigned to receive 3 treatments in a random or
50 Overall, 44 clusters (69 330 pregnant women) were randomly assigned to intervention (22 clusters [36 008 p